Biodesix, Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+40.8% +$8M
$29M
R&D↑+18.9% +$456K
$3M
SG&A↑+13.6% +$3M
$23M
D&A↓-4.3% -$62K
$1M
Operating Income↑+17.9% +$2M
$-7M
EBITDA↓-4.3% -$62K
$1M
Interest Expense↑+17.5% +$307K
$2M
Tax Provision
$0
Net Income↑+15.0% +$2M
$-9M
Operating Margin↑+14.9pts
-32.4%
Net Margin↑+16.5pts
-40.0%
ETR (Continuing Operations)
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+0.6pts
4.3%
Operating Lease Cost↑+0.0% +$0
$600K
Revenue YoY Variation↑+1.5pts
40.8%
Income YoY Variation↑+37.7pts
17.9%
Revenue QoQ Variation↑+19.5pts
32.1%
Income QoQ Variation↑+31.7pts
27.5%